NCT00735826 A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer Status COMPLETED Phase NA
NCT00731380 A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00721513 Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00720304 Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00720083 Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00720070 PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer Status UNKNOWN Phase PHASE3
NCT00716391 TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer. Status COMPLETED Phase PHASE3
NCT00714649 Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT00713219 Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00707655 Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy Status TERMINATED Phase PHASE1/PHASE2
NCT00703638 Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00702481 Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2
NCT00693550 Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer Status COMPLETED Phase N/A
NCT00690872 Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer Status UNKNOWN Phase PHASE2
NCT00686465 Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study Status COMPLETED Phase NA
NCT00681967 Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer Status COMPLETED Phase PHASE1